EPFL spinout Lunaphore has received $2m in a series C extension provided by Swiss Entrepreneurs Fund, adding to an initial $23.6m tranche led by PHC Holdings three months ago.
Lunaphore, a Switzerland-based cancer research and diagnostics equipment spinout of EPFL, added CHF2m ($2m) to close a series C round already backed by medical products group PHC Holdings at $25.6m on Tuesday.
The extension was supplied by Swiss Entrepreneurs Fund, a joint investment vehicle formed by startup support organisation Swiss Entrepreneurs Foundation, insurance provider Swiss Mobiliar and investment banks Credit Suisse and UBS.
PHC Holdings led the $23.6m first tranche with contributions from Alpana Ventures and Occident. The…
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
